Source: PLOS ONE. Unidade: FMRP
Subjects: TRYPANOSOMA CRUZI, VACINAS, IMUNOLOGIA CELULAR, MELANOMA
ABNT
JUNQUEIRA, Caroline et al. Trypanosoma cruzi adjuvants potentiate T cell-mediated immunity induced by a NY-ESO-1 based antitumor vaccine. PLOS ONE, v. 7, n. 5, p. e36245-1 - e236245-13, 2012Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0036245. Acesso em: 14 set. 2024.APA
Junqueira, C., Guerrero, A. T., Galvão Filho, B., Andrade, W. A., Salgado, A. P. C., Cunha, T. M., et al. (2012). Trypanosoma cruzi adjuvants potentiate T cell-mediated immunity induced by a NY-ESO-1 based antitumor vaccine. PLOS ONE, 7( 5), e36245-1 - e236245-13. doi:10.1371/journal.pone.0036245NLM
Junqueira C, Guerrero AT, Galvão Filho B, Andrade WA, Salgado APC, Cunha TM, Ropert C, Campos MA, Penido MLO, Mendonça-Previato L, Previato JO, Ritter G, Cunha F de Q, Gazzinelli RT. Trypanosoma cruzi adjuvants potentiate T cell-mediated immunity induced by a NY-ESO-1 based antitumor vaccine [Internet]. PLOS ONE. 2012 ; 7( 5): e36245-1 - e236245-13.[citado 2024 set. 14 ] Available from: https://doi.org/10.1371/journal.pone.0036245Vancouver
Junqueira C, Guerrero AT, Galvão Filho B, Andrade WA, Salgado APC, Cunha TM, Ropert C, Campos MA, Penido MLO, Mendonça-Previato L, Previato JO, Ritter G, Cunha F de Q, Gazzinelli RT. Trypanosoma cruzi adjuvants potentiate T cell-mediated immunity induced by a NY-ESO-1 based antitumor vaccine [Internet]. PLOS ONE. 2012 ; 7( 5): e36245-1 - e236245-13.[citado 2024 set. 14 ] Available from: https://doi.org/10.1371/journal.pone.0036245